Distribution of lipid-binding regions in human apolipoprotein B-100

Evidence for oxidised low density lipoprotein in synovial fluid from rheumatoid ... Characterization of the membrane-associating domain of the sperm a...
0 downloads 0 Views 3MB Size
Biochemistry 1989, 28, 2477-2484

0.M. (1987) J . Biof. Chem. 262(24), 11833-11840. Shii, K., & Roth, R. A. (1986) Proc. Natf.Acad. Sci. U.S.A. 83, 4147-4151. Shii, K., Yokono, K., Baba, S., & Roth, R. A (1986) Diabetes 35, 675-683. Stoppelli, M. P., Garcia, J. V., Decker, S . J., & Rosner, M. R. (1988) Proc. N a t f . Acad. Sci. U.S.A. (in press).

2477

Tager, H. S., Markese, J., Kramer, K. J., Spiers, R. D., & Childs, C. N. (1986) Biochem. J., 156, 515-520. Terris, S., & Steiner, D. F. (1975) J . Biol. Chem. 250, 8389-8398. Thompson, K. L., Decker, S . J., & Rosner, M. R. (1985) Proc. Natl. Acad. Sci. U.S.A.82, 8443-8447. Thorpe, A., & Duve, H. (1984) Mol. Physiol. 5 , 235-260.

Distribution of Lipid-Binding Regions in Human Apolipoprotein B- 1007 G. Chi Chen,*,t David A. Hardman,f Robert L. Hamilton,$,$Carl M. Mendel,t*ilJames W. Schilling,l Shan Zhu,* Kenneth L a u , l Jinny S. Wong,f and. John P. Kanet*ll*# Cardiovascular Research Institute, Department of Anatomy, Department of Medicine, and Department of Biochemistry and Biophysics, University of California, San Francisco, California 94143-0130, and California Biotechnology, Inc.. Mountain View, California 94303 Received August 8, 1988; Revised Manuscript Received October 9, 1988

The distribution of lipid-binding regions of human apolipoprotein B- 100 has been investigated by recombining proteolytic fragments of B- 100 with lipids and characterizing the lipid-bound fragments by peptide mapping, amino acid sequencing, and immunoblotting. Fragments of B-100 were generated by digestion of low-density lipoproteins (LDL) in the presence of sodium decyl sulfate with either Staphylococcus aureus V8 protease, pancreatic elastase, or chymotrypsin. Particles with electron microscopic appearance of native lipoproteins formed spontaneously when detergent was removed by dialysis from enzyme digests containing fragments of B-100 and endogenous lipids, or from incubation mixtures of delipidated B-100 fragments mixed with microemulsions of exogenous lipids (cholesteryl oleate and egg phosphatidylcholine). Fractionation of the recombinant particles by isopycnic or density gradient ultracentrifugation yielded complexes similar to native LDL with respect to shape, diameter, electrophoretic mobility, and surface and core compositions. Circular dichroic spectra of these particles showed helicity similar to LDL but a somewhat decreased content of /3-structure. Most of the fragments of B-100 were capable of binding to lipids; 12 were identified by direct sequence analysis and 14 by reaction with antisera against specific sequences within B-100. Our results indicate that lipid-binding regions of B-100 are widely distributed within the protein molecule and that proteolytic fragments derived from B-100 can reassociate in vitro with lipids to form LDL-like particles. ABSTRACT:

Low-density lipoproteins (LDL),' the major carriers of cholesterol and cholesteryl esters in human plasma, are spherical particles (18-25 nm in diameter) that consist of a neutral lipid core (mainly composed of cholesteryl esters) surrounded by a polar surface shell (phospholipids, unesterified cholesterol, and protein) (Deckelbaum et al., 1977; Gotto et al., 1986). Apolipoprotein B-100 is the sole protein component of LDL and is the ligand responsible for the binding of LDL to the LDL receptor (Brown & Goldstein, 1986; Mahley et al., 1977, 1984). Moreover, B-100 is one of the largest single polypeptides known, consisting of 4536 amino acid residues, as deduced from cDNA clones (Knott et al., 1986; Law et al., 1986; Yang et al., 1986), and appears to possess a very high affinity for lipids, exemplified by its inability to transfer among lipoprotein particles and by its insolubility in aqueous media after delipidation. This high affinity for lipids suggests a +Thiswork was supported by National Institutes of Health Grants HL 14237 (Arteriosclerosis Specialized Center of Research), HL 01 546 (Clinical Investigator Award), and AM 26743 and by a grant from the Muscular Dystrophy Association. * Author to whom correspondence should be addressed. *Cardiovascular Research Institute, University of California. iDepartment of Anatomy, University of California. Department of Medicine, University of California. California Biotechnology, Inc. # Department of Biochemistry and Biophysics, University of California.

structural role for B- 100 in the formation and maintenance of lipoprotein particles (Kane, 1983). Various model LDL systems have been employed to study the detailed structural organization of LDL particles and the nature of the interaction of B-100 with lipids (Atkinson & Small, 1986). These systems involve the reassembly of intact B- 100 with surface phospholipids alone (Watt & Reynolds, 1981; Walsh & Atkinson, 1983; Dhawan & Reynolds, 1983) or with surface and core lipids (Krieger et al., 1978; Ginsburg et al., 1984; Lundberg & Suominen, 1984). Such systems have clearly demonstrated the ability of B-100 to bind lipids and to form model LDL complexes that exhibit some physicochemical and biological properties similar to those of native LDL. In addition, small tryptic peptides ( M , 300, and >3000 pg of protein/mL, respectively (Figure 5). The observed differences in KD's among the different recombinant particles would be at least qualitatively retained if concentrations had been expressed in units of molarity, since all these particles (including native LDL) had similar protein to lipid ratios and similar diameters. The CD spectra of the recombinant particles showed a wide negative trough around 220 nm, which was similar to that of native LDL, and a deep negative trough around 208 nm, which was not present in native LDL (Figure 6). The general features of the CD spectra of particles prepared from the three different enzyme digests were essentially the same, except for slight variations in magnitude around 220 nm and somewhat larger variations in magnitude around 208 nm. Of the three enzymes used, the CD spectrum of particles prepared from CH digests had the largest negative 208-nm trough. The ratio of the magnitudes of the troughs at 208 to 220 nm was found to be 0.82 f 0.02 (three different preparations) for native LDL, whereas it was 1.12 f 0.06, 1.17 f 0.06, and 1.23 f 0.1 1 (five different preparations each) for particles prepared from SP, EL, and C H digests, respectively. Amino Acid Sequencing and Immunoblotting. To determine the structure of the lipid-bound fragments in the recombinant particles, we have isolated 12 fragments, as indicated by horizontal marks in Figure 4, and subjected them to amino-terminal sequence analysis. Two fragments, designated fragments J and L from EL and CH preparations, respectively, were isolated by preparative SDS-PAGE and analyzed. Nine fragments (A-I) from SP and two fragments (J and K) from EL preparations were isolated by electroblotting onto PVDF membrane following SDS-PAGE and analyzed. Fragment

I

210

)O

I

220

230

40

Wavelength, nm CD spectra of native and recombinant LDL-like particles in 50 mM NaC1/20 mM phosphate buffer, pH 7.5, at 25 "C. Curve 1 , native LDL; curves 2 and 3, recombinant particles prepared from SP and CH digests, respectively. FIGURE 6:

3668-

CI

Kl ......... E, "

--__-_

CI

E

-A

#....., J ,____,L

u G CI

++I C

-B

*D c.,

K

WH

FIGURE 7: Location of the region-specific peptide antisera and the isolated lipid-bound B- 100 fragments. The long horizontal line represents the B-100 molecule. The number above the long horizontal line designates the amino-terminal residue of the synthetic peptide. The isolated fragments (A-L) corresponding to the bands in SDSPAGE pattern, denoted by horizontal marks (Figure 4), were analyzed by amino-terminalsequence analysis. The carboxyl-terminalboundary of the fragments was estimated from the molecular weight of the fragments, as determined by SDS-PAGE. Residues 3 147-3 157, 3359-3367 (Knott et al., 1986), and 3345-3381 (Yang et al., 1986) are the putative receptor-binding domains of B-100.

J from the EL preparation was thus determined by both approaches. The results of amino-terminal sequence analysis in combination with estimation of the molecular weight allowed positioning these fragments in the B-100 molecule (Figure 7). The molecular weights of the 12 fragments were estimated from their mobilities on SDS-PAGE. A mean residue molecular weight of 112 was used for the two amino-terminal fragments (E and F) and 120 was used for the other fragments, to calculate the length of the isolated fragments, because the amino-terminal region of B- 100 was not as highly glycosylated as the rest of the molecule (Knott et al., 1986; Yang et al., 1986). The estimated molecular masses and boundaries are as follows: fragment A, 52 kDa (residues 1910-2344); fragment B, 45 kDa (residues 3240-3616); fragment C, 45 kDa (residues 3 108-3484); fragment D, 29 kDa (residues 24192662); fragment E, 25 kDa (residues 1288-1 5 12); fragment F, 22 kDa (residues 846-1043); fragment G, 20 kDa (residues 2961-3129); fragment H, 17 kDa (residues 2714-2857); fragment I, 15 kDa (residues 3945-4071); fragment J, 43 kDa (residues 2220-2579); fragment K, 24 kDa (residues 25842785); and fragment L, 43 kDa (residues 2222-2581).

2482 Biochemistry, Vol. 28, No. 6,1989 In characterizing the isolated bands from SDS-PAGE patterns, often more than one polypeptide was contained within a seemingly pure band in the gel patterns. For example, fragments B and C (approximately 45 kDa) were found in a given electroblotted band on the PVDF membrane, and at least three components appeared in the band just above it, as indicated by an arrow (Figure 4, lane 2). To identify further the lipid-binding regions of B-100,we have employed the technique of immunoblotting, using 14 antisera raised against region-specific synthetic peptides of 17-40 amino acids in length. The synthetic peptide sequences are 158-1 86,259-280, and 399-415 (Hardman et al., 1987) and 2008-2024, 2068-2091,2301-2325,2404-2425,3120-3 159,3352-3371, 3492-351 1, 3668-3687, 3934-3956, 4004-4021, and 4520-4536 (Innerarity et al., 1987). The results of immunoblotting showed that the amino-terminal 259-280 antiserum reacted with many fragments of SP,EL, and CH preparations but 158-186 and 399-415 antisera only reacted weakly with a few small fragments (